TgAb is detected in 23–29% of differentiated thyroid cancer cases, complicating disease recurrence monitoring, and preoperative Tg levels may be negative in 12% of cases, posing further challenges [12,13,14]. The gene discussed is TG; the disease is thyroid cancer.